Adhering to guideline concordant care improves survival among the different subtypes of T3 N2 non-small cell lung cancer.
Wang JC, Ding L, David EA, Atay SM, Wightman SC, McFadden PM, Harano T, Kim AW. Adhering to guideline concordant care improves survival among the different subtypes of T3 N2 non-small cell lung cancer. JTCVS Open. 2022 Jun; 10:384-392.